Weight loss drugs are set to become a disproportionate share of Lilly's business.

Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

US pharma group says region’s use of ‘one-way insurance system’ to keep down prices is not fair on the industry ...

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...

While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects.

Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the ...

The new $3 billion manufacturing facility will be sited at the Leiden Bio Science Park in Katwijk, and will be Lilly's first ...

Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant ...

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

US pharmaceutical company Eli Lilly said on Monday it will invest around €2.7 billion in a new production facility near the ...

U .S. pharmaceutical company Eli Lilly (LLY) has announced plans to build a $3 billion manufacturing plant in the Netherlands ...

The Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines.